High Sensitive Troponin T (hsTnT) and Copeptin as Prognostic Parameters in Patients With Elective Total Endoprosthesis

NCT01335815 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 200

Last updated 2011-04-14

No results posted yet for this study

Summary

Summary: The purpose of the study is to prove if the biomarker high sensitive troponin T (hsTnT) and the biomarker of endogenous stress copeptin can serve as surrogate parameter of prognosis in patients with elective knee and hip total endoprosthesis.

Conditions

Sponsors & Collaborators

  • Heidelberg University

    lead OTHER

Principal Investigators

  • Evangelos Giannitsis, Prof. Dr. · Heidelberg University

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2011-03-31
Primary Completion
2012-03-31
Completion
2013-03-31

Countries

  • Germany

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01335815 on ClinicalTrials.gov